AngII induces transient phospholipase D activity in the H295R glomerulosa cell model

Molecular and Cellular Endocrinology

Volumn 206, Issue 1-2, 2003, Pages 113-122

  Zheng, Xiangjian ^a   Bollag, Wendy B ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Adrenocortical carcinoma; Aldosterone; NCI H295R cells; Phosphatidic acid; Phosphoinositide 3 kinase; Protein kinase C

Indexed keywords

ANGIOTENSIN; PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PHOSPHOLIPASE D; PROTEIN KINASE B; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR;

ADRENAL CORTEX CARCINOMA; ALDOSTERONE RELEASE; ARTICLE; CANCER CELL; CELL STRAIN; CONTROLLED STUDY; DRUG INHIBITION; ENZYME ACTIVITY; GLOMERULOSA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REGULATORY MECHANISM;

EID: 0041430880     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(03)00211-9     Document Type: Article

References (54)

1. Andresen B.T., Jackson E.K., Romero G.G. Angiotensin II signaling to phospholipase D in renal microvascular smooth muscle cells in SHR. Hypertension. 37:2001;635-639.
2. Barrett P.Q., Bollag W.B., Isales C.M., McCarthy R.T., Rasmussen H. Role of calcium in angiotensin II-mediated aldosterone secretion. Endocr. Rev. 10:1989;1-22.
3. Barrett P.Q., Ertel E.A., Smith M.M., Nee J.J., Cohen C.J. Voltage-gated calcium currents have two opposing effects on the secretion of aldosterone. Am. J. Physiol. 268:1995;C985-C992.
4. Betancourt-Calle S., Bollag W.B., Jung E.M., Calle R.A., Rasmussen H. Effects of angiotensin II and ACTH on MARCKS phosphorylation in glomerulosa cells. Mol. Cell. Endocrinol. 154:1999;1-9.
5. Bird I.M., Hanley N.A., Word R.A., Mathis J.M., McCarthy J.L., Mason J.I., Rainey W.E. Human NCI-H295 adrenocortical carcinoma cells: a model for angiotensin-II-responsive aldosterone secretion. Endocrinology. 133:1993;1555-1561.
6. 2+-regulated expression of steroid hydroxylases in H295R human adrenocortical cells. Endocrinology. 136:1995;5677-5684.
7. Bollag W.B. Measurement of phospholipase D activity. Methods Mol. Biol. 105:1998;151-160.
8. Bollag W.B., Barrett P.Q., Isales C.M., Liscovitch M., Rasmussen H. A potential role for phospholipase-D in the angiotensin-II-induced stimulation of aldosterone secretion from bovine adrenal glomerulosa cells. Endocrinology. 127:1990;1436-1443.
9. Bollag W.B., Jung E.M., Calle R.A. Mechanism of angiotensin II-induced phospholipase D activation in adrenal glomerulosa cells. Mol. Cell. Endocrinol. 192:2002;7-16.
10. Burnay M.M., Python C.P., Vallotton M.B., Capponi A.M., Rossier M.F. Role of the capacitative calcium influx in the activation of steroidogenesis by angiotensin-II in adrenal glomerulosa cells. Endocrinology. 135:1994;751-758.
11. Cantley L.C., Neel B.G. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc. Natl. Acad. Sci. USA. 96:1999;4240-4245.
12. Chan T.O., Rittenhouse S.E., Tsichlis P.N. Akt/PKB and other D3 phosphoinositide-regulated kinases: kinase activation by phosphoinositide-dependent phosphorylation. Annu. Rev. Biochem. 68:1999;965-1014.
13. +. Am. J. Physiol. 276:1999;F674-F683.
14. + in H295R adrenocortical cells. Mol. Cell. Endocrinol. 115:1995;215-219.
15. Colley W., Sung T.-C., Roll R., Jenco J., Hammond S.M., Altshuller Y.M., Bar-Sagi D., Morris A.J., Frohman M.A. Phospholipase D2, a PLD1-related isoform with novel regulatory properties and discrete subcellular localization that provokes cytoskeletal reorganization. Curr. Biol. 7:1997;191-201.
16. Conricode K.M., Brewer K.A., Exton J.H. Activation of phospholipase D by protein kinase C: evidence for a phosphorylation-independent mechanism. J. Biol. Chem. 267:1992;7199-7202.
17. Du, G., Altshuller, Y.M., Kim, Y.H., Han, J.M., Ryu, S.H., Morris, A.J., Frohman, M.A., 2000. Dual requirement for rho and protein kinase C in direct activation of phospholipase D1 through G-protein-coupled receptor signaling. Mol. Biol. Cell 11, 4359-4368.
18. Exton J.H. Phospholipase D. Ann. New York Acad. Sci. 905:2000;61-68.
19. Frohman M.A., Sung T.C., Morris A.J. Mammalian phospholipase D structure and regulation. Biochim. Biophys. Acta. 1439:1999;175-186.
20. Ganguly A., Davis J.S. Role of calcium and other mediators in aldosterone secretion from the adrenal glomerulosa cells. Pharmacol. Rev. 46:1994;417-447.
21. Gillooly D.J., Melendez A.J., Hockaday A.R., Harnett M.M., Allen J.M. Endocytosis and vesicular trafficking of immune complexes and activation of phospholipase D by the human high-affinity IgG receptor requires distinct phosphoinositide 3-kinase activities. Biochem. J. 344:1999;605-611.
22. Hammond S.M., Jenco J.M., Nakashima S., Cadwallader K., Gu Q.-M., Cook S., Nozawa Y., Prestwich G.D., Frohman M.A., Morris A.J. Characterization of two alternately spliced forms of phospholipase D1. J. Biol. Chem. 272:1997;3860-3868.
23. Han J.M., Kim J.H., Lee B.D., Lee S.D., Kim Y., Jung Y.W., Lee S., Cho W., Ohba M., Kuroki T., Suh P.G., Ryu S.H. Phosphorylation-dependent regulation of phospholipase D2 by protein kinase C delta in rat pheochromocytoma PC12. J. Biol. Chem. 277:2002;8290-8297.
24. Hanley N.A., Wester R.M., Carr B.R., Rainey W.E. Parathyroid hormone & parathyroid hormone-related peptide stimulate aldosterone production in the human adrenocortical tumor cell line, NCI-H295. Endocr. J. 1:1993;447-450.
25. Hein L., Barsch G.S., Pratt R.E., Dzau V.J., Kolbilka B.K. Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor gene in mice. Nature. 377:1995;744-747.
26. Houle M.G., Bourgoin S. Regulation of phospholipase D by phosphorylation-dependent mechanisms. Biochim. Biophys. Acta. 1439:1999;135-150.
27. Jung E.M., Betancourt-Calle S., Mann-Blakeney R., Foushee T., Isales C.M., Bollag W.B. Sustained phospholipase D activation in response to angiotensin II but not carbachol in bovine adrenal glomerulosa cells. Biochem. J. 330:1998;445-451.
28. Klein J., Chalifa V., Liscovitch M., Löffelholz K. Role of phospholipase D activation in nervous system physiology and pathophysiology. J. Neurochem. 65:1995;1445-1455.
29. Liscovitch M., Czarney M., Fiucci G., Tang X. Phospholipase D: molecular and cell biology of a novel gene family. Biochem. J. 345:2000;401-415.
30. Lopez I., Burns D.J., Lambeth J.D. Regulation of phospholipase D by protein kinase C in human neutrophils: conventional isoforms of protein kinase C phosphorylate a phospholipase D-related component in the plasma membrane. J. Biol. Chem. 270:1995;19465-19472.
31. Lucas L., Penalva V., Ramirez de Molina A., Del Peso L., Lacal J.C. Modulation of phospholipase D by Ras proteins mediated by its effectors, Ral-GDS, PI3K and Raf-1. Int. J. Oncol. 21:2002;477-485.
32. Mamoon A.M., Baker R.C., Farley J.M. Activation of phospholipase D in porcine tracheal smooth muscle: role of phosphatidylinositol 3-kinase and RhoA activation. Eur. J. Pharmacol. 433:2001;7-16.
33. Martiny-Baron G., Kazanietz M.G., Mischak H., Blumberg P.M., Kochs G., Hug H., Marmé D., Schächtele C. Selective inhibition of protein kinase C isozymes by the indolocarbazole Gö 6976. J. Biol. Chem. 268:1993;9194-9197.
34. Min D.S., Park S.-K., Exton J.H. Characterization of a rat brain phospholipase D isozyme. J. Biol. Chem. 273:1998;7044-7051.
35. Nicholson K.M., Anderson N.G. The protein kinase B/Akt pathway in human malignancy. Cell. Signal. 14:2002;381-395.
36. Nishizuka Y. Protein kinase C and lipid signaling for sustained cellular responses. FASEB J. 9:1995;484-496.
37. Powner D.J., Hodgkin M.N., Wakelam M.J.O. Antigen-stimulated activation of phospholipase D1b by Rac1, ARF6, and PKCα in RBL-2H3 cells. Mol. Biol. Cell. 13:2002;1252-1262.
38. Rainey W.E., Mrotek J.J. Adrenal cortex tumors. Masters J.R.W., Palsson B. Human Cell Culture. 1999;123-135.
39. Rainey W.E., Bird I.M., Sawetawan C., Hanley N.A., McCarthy J.L., McGee E.A., Wester R., Mason J.I. Regulation of human adrenal carcinoma cell (NCI-H295) production of C19 steroids. Endocrinology. 77:1993;731-737.
40. 2+ influx, and protein kinase C activation in sustained cellular responses. Endocr. Rev. 16:1995;649-681.
41. Rizzo M., Romero G. Pharmacological importance of phospholipase D and phosphatidic acid in the regulation of the mitogen-activated protein kinase cascade. Pharmacol. Ther. 94:2002;35-50.
42. Rossier M.F., Burnay M.M., Vallotton M.B., Capponi A.M. Distinct functions of T- and L-type calcium channels during activation of bovine adrenal glomerulosa cells. Endocrinology. 137:1996;4817-4826.
43. Siddiqi A.R., Srajer G.E., Leslie C.C. Regulation of human PLD1 and PLD2 by calcium and protein kinase C. Biochim. Biophys. Acta. 1497:2000;103-114.
44. Singer W.D., Brown H.A., Jiang X., Sternweis P.C. Regulation of phospholipase D by protein kinase C is synergistic with ADP-ribosylation factor and independent of protein kinase activity. J. Biol. Chem. 271:1996;4504-4510.
45. Siragy H.M., Inagami T., Ichiki T., Carey R.M. Sustained hypersensitivity to angiotensin II and its mechanism in mice lacking the subtype-2 (AT2) angiotensin receptor. Proc. Natl. Acad. Sci. USA. 96:1999;6506-6510.
46. 2+ influx. Endocrinology. 140:1999;1385-1391.
47. 2 receptor: new insights into an old system. Regul. Pept. 99:2001;175-182.
48. Toker A. Protein kinases as mediators of phosphoinositide 3-kinase signaling. Mol. Pharmacol. 57:2000;652-658.
49. Unger T. The role of the renin-angiotensin system in the development of cardiovascular disease. Am. J. Cardiol. 89:(Suppl.):2002;3A-10A.
50. Vanhaesebroeck B., Leevers S.J., Ahmadi K., Timms J., Katso R., Driscoll P.C., Woscholski R., Parker P.J., Waterfield M.D. Synthesis and function of 3-phosphorylated inositol lipids. Annu. Rev. Biochem. 70:2001;535-602.
51. Vivanco I., Sawyers C.L. The phosphatidylinositol 3-kinase-Akt pathway in human cancer. Nat. Rev. Cancer. 2:2002;489-501.
52. 2 receptor leads to increased cell numbers in different brain structures of mice. Regul. Pept. 99:2001;209-216.
53. Waggoner D.W., Xu J., Singh I., Jasinska R., Zhang Q.-X., Brindley D.N. Structural organization of mammalian lipid phosphate phosphatases: implications for signal transduction. Biochim. Biophys. Acta. 1439:1999;299-316.
54. Zhang Y., Altshuller Y.M., Hammond S.M., Morris A.J., Frohman M.A. Loss of receptor regulation by a phospholipase D1 mutant unresponsive to protein kinase C. EMBO J. 18:1999;6339-6348.